Cresco Labs Inc.
CL
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.69% | -5.33% | -5.28% | -6.55% | -7.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.69% | -5.33% | -5.28% | -6.55% | -7.28% |
| Cost of Revenue | -9.52% | -11.90% | -15.92% | -16.28% | -10.20% |
| Gross Profit | -3.55% | 2.40% | 8.18% | 5.98% | -3.83% |
| SG&A Expenses | -5.73% | -13.56% | -22.33% | -23.89% | -22.36% |
| Depreciation & Amortization | -16.28% | -11.28% | 27.78% | 39.28% | 26.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.41% | -12.50% | -17.17% | -17.84% | -14.10% |
| Operating Income | 5.67% | 68.88% | 243.40% | 280.41% | 114.69% |
| Income Before Tax | 77.09% | 92.77% | 99.73% | 27.78% | 12.47% |
| Income Tax Expenses | 35.27% | 51.36% | 13.22% | -58.43% | -58.83% |
| Earnings from Continuing Operations | 52.19% | 66.37% | 84.66% | 36.58% | 29.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1,659.05% | -422.15% | -143.99% | -149.69% | -106.14% |
| Net Income | 45.90% | 57.59% | 80.14% | 26.21% | 26.60% |
| EBIT | 5.67% | 68.88% | 243.40% | 280.41% | 114.69% |
| EBITDA | -1.92% | 32.88% | 102.38% | 111.68% | 62.02% |
| EPS Basic | 48.20% | 59.83% | 81.89% | 33.93% | 33.10% |
| Normalized Basic EPS | -240.65% | -500.73% | -203.64% | -3,481.82% | 627.78% |
| EPS Diluted | 48.20% | 59.83% | 81.89% | 33.93% | 33.10% |
| Normalized Diluted EPS | -240.65% | -500.73% | -203.64% | -3,481.82% | 627.78% |
| Average Basic Shares Outstanding | 4.40% | 6.71% | 9.13% | 11.57% | 10.57% |
| Average Diluted Shares Outstanding | 4.40% | 6.71% | 9.13% | 11.57% | 10.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |